allylamine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Al Ameri, J; Alsuraifi, A; Curtis, A; Hoskins, C | 1 |
| Anagnostopoulos, C; Andreyev, HJ; Lalji, A; Thomas, K; Wedlake, L | 1 |
| Kjaer, M; Nielsen, H | 1 |
3 other study(ies) available for allylamine and Neoplasms
| Article | Year |
|---|---|
Effect of Poly(allylamine) Molecular Weight on Drug Loading and Release Abilities of Nano-Aggregates for Potential in Cancer Nanomedicine.
Topics: Allylamine; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Weight; Nanomedicine; Nanoparticles; Neoplasms; Particle Size; Reproducibility of Results | 2020 |
Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Topics: Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Antineoplastic Agents; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Malabsorption Syndromes; Male; Middle Aged; Neoplasms; Quality Assurance, Health Care; Radiotherapy; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2009 |
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets | 1988 |